Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Baxter
Moodys
Mallinckrodt
Teva
Express Scripts

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 8,716,462

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,716,462
Title:Levels and/or sustainability of DNA-based gene expression
Abstract: The invention encompasses methods for improving the level and/or sustainability of expression for a target nucleic acid in a eukaryotic cell comprising: (a) modifying the target nucleic acid to introduce or to comprise signals that limit or constrain the positions of nucleosome cores, and (b) introducing the modified target nucleic acid into the eukaryotic cell, wherein the modified target nucleic acid has improved levels and/or sustainability of expression compared to original unmodified nucleic acid.
Inventor(s): Fire; Andrew (Washington, DC), Gracey; Lia (Stanford, CA), Lui; Weng-Onn (Stockholm, SE)
Assignee: Carnegie Institution of Washington (Washington, DC) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA)
Application Number:12/162,243
Patent Claims:see list of patent claims

Details for Patent 8,716,462

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Carnegie Institution of Washington (Washington, DC) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA) 2026-01-27 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Carnegie Institution of Washington (Washington, DC) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA) 2026-01-27 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Carnegie Institution of Washington (Washington, DC) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA) 2026-01-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Chubb
Colorcon
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.